Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation

Addictive Behaviors

Volumn 37, Issue 4, 2012, Pages 565-568

  Schnoll, Robert A ^a   Wileyto, E Paul ^a   Lerman, Caryn ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cessation; Nicotine patch; Tobacco; Weight gain

Indexed keywords

NICOTINE; PLACEBO;

ADULT; ARTICLE; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; SELF REPORT; SMOKING CESSATION; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; TREATMENT DURATION; WEIGHT GAIN; WEIGHT REDUCTION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; ANTI-OBESITY AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NICOTINE; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; WEIGHT GAIN; YOUNG ADULT;

EID: 84857051832     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2011.12.009     Document Type: Article

References (31)

1. Albanes D., Jones D.Y., Micozzi M.S., Mattson M.E. Associations between smoking and body weight in the US population: Analysis of NHANES II. American Journal of Public Health 1987, 77:439-444.
2. Allen S.S., Hatsukami D., Brintnell D.M., Bade T. Effect of nicotine replacement therapy on post-cessation weight gain and nutrient intake: A randomized controlled trial of postmenopausal female smokers. Addictive Behavior 2005, 30:1273-1280.
3. Beasley T.M. Seemingly unrelated regression (SUR) models as a solution to path analytic models with correlated errors. Multiple Linear Regression Viewpoints 2008, 34:1-7.
4. Benowitz N.L., Jacob P., Ahijevych K., Jarvis M.J., Hall S., LeHouezec J. Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research 2002, 4:149-159.
5. Bize R., Willi C., Chiolero A., Stoianov R., Payot S., Locatelli I., et al. Participation in a population-based physical activity programme as an aid for smoking cessation: a randomized trial. Tobacco Control 2010, 19:488-494.
6. Donny E.C., Caggiula A.R., Weaver M.T., Levin M.E., Sved A.F. The reinforcement-enhancing effects of nicotine: Implications for the relationship between smoking, eating and weight. Physiology & Behavior 2011, 104:143-148.
7. Ferguson S.G., Shiffman S., Rohay J.M., Gitchell J.G., Garvey A.J. Effect of compliance with nicotine gum dosing on weight gained during a quit attempt. Addiction 2010, 106:651-656.
8. Froom P., Melamed S., Benbassat J. Smoking cessation and weight gain. Journal of Family Practice 1998, 46:460-464.
9. Gonzales D., Rennard S.I., Nides M., Oncken C., Azoulay S., Billing C.B. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release buprorion and placebo for smoking cessation: a randomized controlled trial. Journal of the American Medical Association 2006, 296:47-55.
10. Gross J., Stitzer M.L., Maldonado J. Nicotine replacement: effects on post-cessation weight gain. Journal of Clinical and Consulting Psychology 1989, 57:87-92.
11. Hall S.M., Ginsberg D., Jones R.T. Smoking cessation and weight gain. Journal of Counseling and Clinical Psychology 1986, 54:342-346.
12. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 1991, 86:1119-1127.
13. Hughes J.R., Keely J.P., Niaura R.S., Ossip-Klein D.J., Richmond R.L., Swan G.E. Measures of abstinence in clinical trials: Issues and recommendations. Nicotine & Tobacco Research 2003, 5:13-25.
14. Hurt R.D., Sachs D.P., Glover E.D., Offord K.P., Johnston J.A., Dale L.C., et al. A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine 1997, 23:1195-1202.
15. King A., de Wit H., Riley R.C., Cao D., Niaura R., Hatsukami D. Efficacy of naltrexone in smoking cessation: A preliminary study and an examination of sex differences. Nicotine & Tobacco Research 2006, 8:671-682.
16. Klesges R.C., Klesges L.M. Cigarette smoking as a weight loss strategy in a university population. International Journal of Eating Disorders 1988, 7:413-419.
17. Lerman C., Kaufmann V., Rukstalis M., Patterson F., Perkins K., Audrain-McGovern J. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: A randomized trial. Annals of Internal Medicine 2004, 140:426-433.
18. Levine M.D., Perkins K.A., Kalarchian M.A., Cheng Y., Houck P.R., Slane J.D., et al. Bupropion and cognitive behavioral therapy for weight-concerned women smokers. Archives of Internal Medicine 2010, 170:543-550.
19. Lin D.Y., Fleming T.R., De Gruttola V. Estimating the proportion of treatment effect explained by a surrogate marker. Statistical Medicine 1997, 16:1515-1527.
20. MacKinnon D.P., Fairchild A.J., Fritz M.S. Mediation analysis. Annual Review of Psychology 2007, 58:593-614.
21. Meyers A.W., Kleges R.C., Winders S.E., Ward K.D., Peterson B.A., Eck L.H. Are weight concerns predictive of smoking cessation? A prospective analysis. Journal of Consulting and Clinical Psychology 1997, 65:448-452.
22. O'Malley S.S., Cooney J.L., Krishnan-Sarin S., Dubin J.A., McKee S.A., Cooney N.L., et al. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Archives of Internal Medicine 2006, 166:667-674.
23. Parsons A.C., Shraim M., Inglis J., Aveyard P., Hajek P. Interventions for preventing weight gain after smoking cessation. Cochrane Database System of Reviews 2009, 21:CD006219.
24. Potter B.K., Pederson L.L., Chan S.S., Aubut J.A., Koval J.J. Does a relationship exist between body weight, concerns about weight, and smoking among adolescents? An integration of the literature with an emphasis on gender. Nicotine & Tobacco Research 2004, 6:397-425.
25. Saules K.K., Schuh L.M., Arfken C.L., Reed K., Kilbey M.M., Schuster C.R. Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy. American Journal of Addiction 2004, 13:438-446.
26. Schnoll R.A., Patterson F., Wileyto E.P., Heitjan D., Shields A., Asch D., et al. Effectiveness of extended duration transdermal nicotine therapy: A randomized trial. Annals of Internal Medicine 2010, 152:144-151.
27. Sood A., Ebbert J.O., Clark M.M., Croghan I.T., Schroeder D.R., Hays J.T. Sibutramine for weight gain attenuation during smoking cessation with varenicline: A pilot study. Nicotine & Tobacco Research 2009, 11:1479-1484.
28. Spring B., Howe D., Berendsen M., McFadden H.G., Hitchcock K., Rademaker A.W., et al. Behavioral intervention to promote smoking cessation and prevent weight gain: A systematic review. Addiction 2009, 104:1472-1486.
29. Toll B.A., Leary V., Wu R., Salovey P., Meandzija B., O'Malley S.S. A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain. Addictive Behavior 2008, 33:173-179.
30. Vittinghoff E., Sen S., McCulloch C.E. Sample size calculations for evaluating mediation. Statistical Medicine 2009, 28:541-557.
31. Zellner A. An efficient method of estimating seemingly unrelated regressions and tests for aggregation bias. Journal of the American Statistical Association 1962, 57:348-368.